Entries by aaron

Illegal hospital, clinic busted in Gurugram; 2 quacks arrested

Gurugram: Busting an illegal hospital and clinic in Ambedkar colony and Chakkarpur village in Gurugram, a joint team of the chief minister’s flying squad and the health department arrested two quacks on Saturday in connection with the case. Meanwhile, two more accused in this case are absconding.  The authorities raided and sealed the SD Hospital […]

Health Bulletin 12/February/2024

Here are the top health stories for the day: Surgeon and nursing home to compensate for removing minor patient’s ovary without proper assessment The Telangana State Consumer Disputes Redressal Commission dismissed a surgeon’s appeal challenging a District Commission’s order. The District Commission had held the doctor and a nursing home accountable for causing functional disability […]

Dispelling Myths: Exploring Diabetes Risk in Non-Vegetarians – Dr V.K Varmani

The HbA1c test, or glycated hemoglobin test, is a crucial tool in diabetes management. It measures the average blood sugar level over the past 2-3 months, providing a comprehensive view of long-term glucose control. This test is essential for assessing the effectiveness of diabetes management plans and helping individuals and healthcare providers make informed decisions […]

Akums Drugs and Pharma files draft IPO papers with Sebi

New Delhi: Akums Drugs and Pharmaceuticals Ltd has filed draft papers with capital markets regulator Sebi to raise funds through an initial public offering (IPO). The initial share-sale is a combination of fresh issue of equity shares worth Rs 680 crore and an offer-for-sale (OFS) of 1.86 crore shares by promoters and an existing investor, according […]

Beta-blocker cessation benefits HFpEF patients with chronotropic incompetence and smaller end-systolic left ventricular volume: JAMA

Spain: In patients with heart failure with preserved ejection fraction (HFpEF) and chronotropic incompetence, beta-blocker cessation may be particularly beneficial in patients with smaller end-systolic left ventricular volume, a post hoc analysis of a randomized clinical trial has shown. In the analysis that enrolled 52 patients with HFpEF and chronotropic incompetence taking β-blocker treatment, “lower […]

Ensitrelvir Reduces symptoms in mild to moderate COVID-19: Phase 3 Trial

Despite vaccination efforts, COVID-19 treatment options are still needed, especially for those with mild to moderate symptoms. Ensitrelvir, a novel antiviral medication, was evaluated in a randomized clinical trial to assess its ability to reduce symptom duration and improve patient outcomes. As the COVID-19 pandemic continues, the search for effective treatment options remains paramount. This […]